Sterne Agee Sees Teva Pharmaceutical Outperformance Continuing By: Benzinga via Benzinga April 16, 2014 at 15:18 PM EDT On Wednesday, Sterne Agee initiated coverage on shares of Teva Pharmaceutical Industries (NYSE: TEVA) with a Neutral rating and $53 ... Read More >> Related Stocks: Teva Pharmaceutical Industries ADR